PRISMAP: A European network for medical radioisotope production and research

October 1, 2021, 12:00PMNuclear News
A conceptual image of collaboration across Europe. (Image: PRISMAP/SCIPROM)

Only a few of the more than 3,000 radioisotopes that scientists have synthesized in the laboratory are regularly used in diagnostic or therapeutic medicine. One significant barrier to the development of new medical radioisotopes is the difficulty of gaining access to radionuclides during the early stages of development and research. PRISMAP is a new medical radionuclide program designed to streamline that access for medical research in the European Union and the United Kingdom.

To continue reading, log in or create a free account!

Related Articles

JT-60SA upgraded and ready for restart

May 15, 2026, 12:11PMNuclear News

The project team for the world’s largest operational tokamak, JT-60SA, has announced that it is getting ready to resume operations. The machine has been undergoing upgrades since 2024, with...

Beyond the grid

April 21, 2026, 11:54AMNuclear NewsCraig Piercy

In this month’s issue of Nuclear News, readers will find coverage of the “other” areas where nuclear technology is pushing into new frontiers. From marine nuclear propulsion to nuclear...